首页> 美国卫生研究院文献>BMC Biotechnology >Site-directed in vitro immunization leads to a complete human monoclonal IgG4λ that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands
【2h】

Site-directed in vitro immunization leads to a complete human monoclonal IgG4λ that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands

机译:定点体外免疫可产生完整的人单克隆IgG4λ可特异性结合CTLA-4(CD152)的CDR2区而不会干扰天然配体的结合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe ability to acquire fully human monoclonal antibodies (mAbs) with pre-defined specificities is critical to the development of molecular tags for the analysis of receptor function in addition to promising immunotherapeutics. Yet most of the arriving affinity maturated and complete human immunoglobulin G (IgG) molecules, which are actually derived from single human B cells, have not widely been used to study the conserved self antigens (Ags) such as CD152 (cytotoxic T lymphocyte antigen-4, CTLA-4) because proper hosts are lacking.
机译:背景技术除了有望的免疫疗法之外,获得具有预定特异性的完全人单克隆抗体(mAb)的能力对于开发用于分析受体功能的分子标签至关重要。然而,实际上来自单个人B细胞的大多数到达的亲和力成熟且完整的人免疫球蛋白G(IgG)分子尚未广泛用于研究保守的自身抗原(Ags),例如CD152(细胞毒性T淋巴细胞抗原- 4,CTLA-4),因为缺少合适的主机。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号